The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide
- PMID: 332502
- DOI: 10.1007/BF00561401
The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide
Abstract
Plasma concentrations of pancuronium following single dose administration in six patients, and following multiple dose administration in four patients, all undergoing renal transplantation surgery, were measured using a fluorimetric method. A two-compartment open model was used in the pharmacokinetic analysis of the data. Comparison of the pharmacokinetic findings with data previously obtained for patients undergoing elective surgery but having normal renal function indicated that the clearance of the drug was reduced significantly in the patients with renal failure, and that in these individuals the half-life was increased significantly. Measurement of the evoked mechanical twitch response concurrently with plasma concentration monitoring of pancuronium confirmed that the prolongation of half-life in the patients with renal failure was often but not always associated with an extended duration of neuromuscular blockade and furthermore that the rate of recovery from block might also be prolonged. The clinical implications of these findings are discussed.
Similar articles
-
Clinical pharmacokinetics of pancuronium bromide.Eur J Clin Pharmacol. 1976 Sep 30;10(5):367-72. doi: 10.1007/BF00565627. Eur J Clin Pharmacol. 1976. PMID: 789085 Clinical Trial.
-
Disposition kinetics of pancuronium bromide in patients with total biliary obstruction.Br J Anaesth. 1977 Nov;49(11):1103-8. doi: 10.1093/bja/49.11.1103. Br J Anaesth. 1977. PMID: 588390
-
Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.Br J Anaesth. 1981 Oct;53(10):1049-53. doi: 10.1093/bja/53.10.1049. Br J Anaesth. 1981. PMID: 6117300
-
Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.Anesth Analg. 1986 Mar;65(3):233-9. Anesth Analg. 1986. PMID: 2869721
-
Pancuronium bromide.Ann Intern Med. 1978 Jan;88(1):64-8. doi: 10.7326/0003-4819-88-1-64. Ann Intern Med. 1978. PMID: 339801 Review.
Cited by
-
Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.Br J Pharmacol. 1978 Jun;63(2):287-93. doi: 10.1111/j.1476-5381.1978.tb09759.x. Br J Pharmacol. 1978. PMID: 27272 Free PMC article.
-
Guide to drug dosage in renal failure.Clin Pharmacokinet. 1988 Nov;15(5):326-54. doi: 10.2165/00003088-198815050-00005. Clin Pharmacokinet. 1988. PMID: 3060292 Review. No abstract available.
-
Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure.Eur J Clin Pharmacol. 1981;20(4):293-8. doi: 10.1007/BF00618780. Eur J Clin Pharmacol. 1981. PMID: 6118278
-
POST-ANAESTHETIC APNOEA : AN EVENT OF THE PAST?Med J Armed Forces India. 1998 Jan;54(1):63-64. doi: 10.1016/S0377-1237(17)30417-3. Epub 2017 Jun 26. Med J Armed Forces India. 1998. PMID: 28775420 Free PMC article. No abstract available.
-
Influence of renal and hepatic function on pharmacodynamics and pharmacokinetics of non-depolarizing muscle relaxants.Pharm Weekbl Sci. 1987 Apr 24;9(2):56-60. doi: 10.1007/BF01960736. Pharm Weekbl Sci. 1987. PMID: 2954027 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources